Genomic profiling shows that many solid tumors are characterized by specific driver
aberrations, and this has expanded the therapeutic options for many patients. The mitogen …

Thyroid cancer incidence is increasing at an alarming rate, almost tripling every decade. In
2017, it was the fifth most common cancer in women. Although the majority of thyroid tumors …

Background: Cancer stem cells (CSCs) are highly tumorigenic, chemotherapy-resistant,
tumor growth-sustaining, and are implicated in tumor recurrence. Previous studies have …

Resistance against conventional chemotherapeutic agents is one of the main reasons for
tumor relapse and poor clinical outcomes in cancer patients. Various mechanisms are …

Anaplastic thyroid cancer (ATC) is undoubtedly the thyroid cancer histotype with the poorest
prognosis. The conventional treatment includes surgery, radiotherapy, and conventional …

Anaplastic thyroid carcinoma (ATC) is an orphan disease and in most patients fatal. So far
no established treatment is available that prolongs survival. Several large retrospective …

Anaplastic thyroid carcinoma (ATC) is a highly aggressive form of thyroid cancer. A single-
institution thyroid cancer cohort of ATC was identified within the last 10 years at our …

Anaplastic thyroid carcinoma is an uncommon carcinoma representing 1 to 4% of all thyroid
cancers. The carcinoma is most common in females of the eight decades. It is a locally …

Simple Summary According to the American Cancer Society, approximately 53,000 new
cases of thyroid cancer were diagnosed and more than 2200 people died from the disease …

Anaplastic thyroid cancer (ATC) is a rare but highly aggressive kind of thyroid cancer.
Various therapeutic methods have been considered for the treatment of ATC, but its …